Home  /  Resource Library  /  Risk of Infection with Ibrutinib in Patients with B-Cell Malignancies: A Meta-Analysis of Phase III Randomized Controlled Trials

Risk of Infection with Ibrutinib in Patients with B-Cell Malignancies: A Meta-Analysis of Phase III Randomized Controlled Trials

Retrospective study examined the risk of infection associated with Ibrutinib treatment in patient with various lymphomas.